← Back to Search

Shared Decision-Making Tool for Osteoarthritis

N/A

Waitlist Available

Led By Daniel H Wiznia, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, immediately after intervention, and week 4

Awards & highlights

Study Summary

This trial will test whether using a SDMT will help patients with knee osteoarthritis make informed decisions about their treatment options.

Eligible Conditions

Osteoarthritis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, immediately after intervention, and week 4

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, immediately after intervention, and week 4

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after intervention, and week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Impact of the shared decision-making tool on a patient's willingness to seek treatment for knee osteoarthritis

Secondary outcome measures

Change in Impact of SDMT on decision-making

Change in Impact of SDMT on patient understanding

Trial Design

2Treatment groups

Experimental Treatment

Group I: Shared Decision-Making ToolExperimental Treatment3 Interventions

Patients in the treatment arm of the study will watch a short video and then receive standard of care counseling with an orthopaedic surgeon that includes discussion of the shared decision-making tool.

Group II: ControlExperimental Treatment2 Interventions

Patients in the control arm of the study will watch a short video and then receive standard of care counseling with an orthopaedic surgeon.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,736,423 Total Patients Enrolled

3 Trials studying Osteoarthritis

299 Patients Enrolled for Osteoarthritis

Daniel H Wiznia, MDPrincipal InvestigatorYale University

Media Library

Shared Decision-Making Tool Clinical Trial Eligibility Overview. Trial Name: NCT05411939 — N/A

Osteoarthritis Research Study Groups: Control, Shared Decision-Making Tool

Osteoarthritis Clinical Trial 2023: Shared Decision-Making Tool Highlights & Side Effects. Trial Name: NCT05411939 — N/A

Shared Decision-Making Tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT05411939 — N/A

Osteoarthritis Patient Testimony for trial: Trial Name: NCT05411939 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation provide opportunities for participants younger than 40 years old?

"According to the trial's enrolment rules, individuals need be between 45 and 65 years old in order to qualify."

Answered by AI

Is this experiment currently accepting participants?

"Unfortunately, clinicaltrials.gov has indicated that this medical trial is not currently seeking participants. The study was first published on November 30th 2022 and last modified on the 22nd of November in the same year. However, there are still 693 alternative trials actively enrolling patients at present."

Answered by AI

Is it feasible for me to participate in this research initiative?

"This clinical trial is recruiting two hundred individuals, between the ages of forty-five and sixty-five, who are suffering from knee osteoarthritis. Moreover, to be eligible for this study participants must have mild to moderate pain which has been diagnosed as being caused by their condition."

Answered by AI